Prof. Dr. med. Mario Fabri - Curriculum Vitae

Education and professional career

2016: W2 Professor for Infectious Diseases in Dermatology
2016: Habilitation in Dermatology and Venereology
2014: Board Certification for Dermatology and Venereology
2007: Dissertation, Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne
2005: Approbation in Medicine
1998-2005: Studies in Medicine at: University of Cologne, Germany; Harvard Medical School, Boston, USA: University of Nice, France

Awards, distinctions and professional activities

since 2016: Attending  in Dermatology and Venereology, University of Cologne
since 2016: Member of the Committee Antiinfektiva, Resistenz und Therapieüberwachung (Robert Koch Institute, Germany)
since 2015: Associated Principal Investigator of the CRC670
since 2013: Principal Investigator of the CRC829
2013-2015: Board member of the Junior Faculty Club of the University of Cologne
since 2012: Board member of the Section Dermatologic Infections and Tropical Diseases (ADI-TD) of the German Dermatology Society (DDG)
since 2012: Founding and Board member of the Section Research of the German STI Society (DSTIG)
2012: Future Leader in Dermatology Awardee, European Society for Dermatological Research
2011-2015: Head of Junior Research Group (NRW-Nachwuchsgruppe) Medical Faculty, University of Cologne
since 2011: Head of Serology Lab Dermatology and Venereology, University of Cologne
2011-2014: Resident in Dermatology and Venereology Dermatology and Venereology, University of Cologne
2010: Young Investigator Award, European Skin Research Foundation
2008-2010: Postdoctoral Research Grant, German Research Association
2008-2010: Postdoc with Robert L Modlin, Dermatology, David Geffen School of Medicine at University of California, Los Angeles, USA
2006-2007: Resident in Dermatology and Venereology Dermatology and Venereology, University of Cologne

Selected publications

Steiger J, Stephan A, Inkeles MS, Realegeno S, Bruns H, Kröll P, de Castro Kroner J, Sommer A, Batinica M, Pitzler L, Kalscheuer R, Hartmann P, Plum G, Stenger S, Pellegrini M, Brachvogel B, Modlin RL, Fabri M: Imatinib triggers phagolysosome acidification and antimicrobial activity against Mycobacterium bovis Bacillus Calmette-Guérin in glucocorticoid-treated human macrophages. J Immunol. (2016) in press.

Stephan A, Batinica M, Steiger J, Pia Hartmann, Zaucke F, Bloch W, Fabri M: LL37:DNA complexes provide antimicrobial activity against intracellular bacteria in human macrophages. Immunology (2016) in press.

Mrotzek C, Felcht M, Sommer A, Schrader A, Klemke CD, Herling M, Schlaak M, Fabri M: Vitamin D controls apoptosis and proliferation of cutaneous T cell lymphoma cells. Exp Dermatol. (2015) Oct;24(10):798-800.

Sommer A, Fabri M: Vitamin D regulates cytokine patterns secreted by dendritic cells to promote differentiation of IL-22-producing T cells. PLoS One. (2015) Jun 24;10(6):e0130395.

Bruns H, Büttner M, Fabri M, Mougiakakos D, Bittenbring JT, Hoffmann MH, Beier F, Pasemann S, Jitschin R, Hofmann AD, Neumann F, Daniel C, Maurberger A, Kempkes B, Amann K, Mackensen A, Gerbitz A: Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high grade B-cell lymphoma. Sci Transl Med. 2015 Apr 8;7(282):282ra47.

Klug-Micu GM, Stenger S, Sommer A, Liu PT, Krutzik SR, Modlin RL, Fabri M: CD40L and IFN-? induce an antimicrobial response against M. tuberculosis in human monocytes. Immunology. (2013) May;139(1):121-8.

Bruns H, Stegelmann F, Fabri M, Döhner K, van Zandbergen G, Wagner M, Skinner M, Modlin RL, Stenger S: Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages. J Immunol. (2012) Oct 15;189(8):4069-78.

Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, Lee HM, Krutzik SR, Schenk M, Sieling PA, Teles R, Montoya D, Iyer SS, Bruns H, Lewinsohn DM, Hollis BW, Hewison M, Adams JS, Steinmeyer A, Zügel U, Cheng G, Jo EK, Bloom BR, Modlin RL: Vitamin D is Required for IFN-?-Mediated Antimicrobial Activity of Human Macrophages. Sci Transl Med. (2011) Oct 12;3(104):104ra102.